May 5, 2021

Featuring perspectives from Dr Joyce O'Shaughnessy on following topics:

• Introduction (0:00)
• Case Presentations from Alan B Astrow, MD on Chemotherapy for Triple-Negative Breast Cancer (TNBC)
• • A woman in her late 80s with triple-negative lobular carcinoma (1:54)
  • A woman in her mid-60s with triple-negative, node-positive breast cancer (6:30)
  • A woman in her early 30s with triple-negative, node-negative infiltrating ductal carcinoma (IDC) (14:39)
• San Antonio Breast Cancer Symposium (SABCS®) Review — Immunotherapy for Advanced TNBC (20:25)
• Case Presentations from Dr Astrow and SABCS Review of Data on Immunotherapy Combinations and PARP Inhibition for TNBC
• • A woman in her early 40s with metastatic TNBC (31:08)
  • A woman in her early 60s with a germline BRCA1 mutation and locally advanced breast cancer (36:14)
• Case Presentations from Dr Astrow on Triple-Negative Small Cell Carcinoma of the Breast and Triple-Negative IDC; Sacituzumab Govitecan for Patients with TNBC
• • A woman in her mid-40s with triple-negative small cell carcinoma of the breast (48:11)
  • A woman in her late 30s with triple-negative IDC (51:44)

CME information and select publications